|
HAQ
|
SF-6D
|
EQ-5D
|
SF-36 PCS
|
---|
EARLY RA
|
REM (n = 7)
|
0.14 ± 0.2
|
0.74 ± 0.15
|
0.92 ± 0.10
|
42.7 ± 11.7
|
LDA (n = 26)
|
0.39 ± 0.42
|
0.70 ± 0.15
|
0.81 ± 0.16
|
41.8 ± 7.1
|
MDA/HDA (n = 25)
|
1.05 ± 0.81
|
0.60 ± 0.13
|
0.71 ± 0.19
|
33.1 ± 9.8
|
P Value
|
<0.01
|
0.01
|
0.01
|
0.006
|
LATE RA
|
REM (n = 80)
|
0.41 ± 0.59
|
0.75 ± 0.15
|
0.89 ± 0.12
|
46.3 ± 8.3
|
LDA (n = 124)
|
0.78 ± 0.71
|
0.65 ± 0.14
|
0.77 ± 0.16
|
37.6 ± 10.9
|
MDA/HDA (n = 94)
|
1.30 ± 0.72
|
0.57 ± 0.11
|
0.65 ± 0.22
|
28.9 ± 8.8
|
P Value
|
<0.01
|
<0.01
|
<0.01
|
<0.01
|
- EQ-5D, Euro Quality of life 5 dimensions; HAQ, Health Assessment Questionnaire; LDA, low disease activity; MDA/HDA moderate disease activity/high disease activity; RA, rheumatoid arthritis; REM, remission; SF-6D, Short Form 6 dimensions; SF-36 PCS, Short Form 36 Physical Component Score.